This finding may be of pathophysiological relevance considering that mRNA expression of some of the most well-studied and therapeutically targeted non-odorant GPCRs in the heart, including the beta-1 adrenergic receptor and the angiotensin II receptor type 1, is altered with heart failure and correlates with the severity of the disease [14,15]. The gene discussed is AGTR1; the disease is heart failure.